Mehmet Uğur Karabat

Dr. Mehmet Uğur Karabat

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer

7 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
IÖilhan özdemir
ilhan özdemir
Background/Objectives: Melanoma is an aggressive skin cancer with high metastatic potential and poor prognosis in advanced stages. Hesperidin, a natural flavonoid, has shown anticancer properties across various malignancies. This study aimed to evaluate the antiproliferative and pro-apoptotic effects of Hesperidin, alone and in combination with Cisplatin, on the human epidermoid carcinoma cell line A431. Materials and Methods: A431 cells were cultured under standard conditions and treated with different concentrations of Hesperidin and Cisplatin for 48 h. Cell viability was assessed using the MTT assay. Apoptosis was evaluated by Annexin V-FITC/PI staining and caspase-3/7 activity assays. Expression levels of Bax, caspase-3/7, and survivin were measured by RT-qPCR. Results: Hesperidin significantly reduced cell viability at both 24 and 48 h. Annexin V/PI staining revealed increased apoptosis, with the highest apoptotic ratio in the Hesperidin + Cisplatin group (p < 0.001). Caspase-3/7 activity was markedly elevated in Hesperidin-treated cells. RT-qPCR showed upregulation of Bax and caspase-3/7 and downregulation of survivin. Conclusions: Hesperidin demonstrated significant cytotoxic and pro-apoptotic effects in A431 cells. When combined with Cisplatin, a synergistic enhancement of apoptosis was observed. These findings support the potential of Hesperidin as a complementary agent in carcinoma therapy, pending further in vivo and clinical validation.

22 June 2021 in CHILD`S HEALTH
Verified
Journal Article
Open access
PDF file
CBCaner Baysan
Caner Baysan
SYSeher Palanbek Yavaş
Seher Palanbek Yavaş
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
Background. Vaccination is an important health service that reduces the morbidity and mortality of infectious diseases. In our study, it was aimed to examine the knowledge, attitude, risk perception of parents about vaccine refusal, and the vaccination status of their children in a province of Turkey with a low socioeconomic level. Materials and methods. In the study designed in a cross-sectional type, 105 parents (participation rate: 80.2 %) who rejected the vaccine were reached. Results. The most refused vaccine by the parents is DaBT-İPA-Hib (90.5 %) and the least rejected vaccine is BCG (58.1 %). It was determined that who thought vaccines have no benefits (p = 0.003), those who were doubtful about the content of the vaccine (p = 0.001), those who did not want the vaccine due to their religious beliefs (p = 0.006), and those who believed in natural immunity (p = 0.002) were less convinced about vaccinating their children at a statistically significant level than the other group. The vaccine with the highest rate is HAV (35.0 %, n = 7), and the vaccine with the lowest rate is BCG (8.3 %, n = 1) in terms of the rate of vaccination that they declare to be convinced to have it. Conclusions. When evaluated on the causes of vaccine refusal and persuasion, the primary source of information is provided by health workers with scientific evidence through different communication methods (social media, etc.) should be reached.

25 July 2025 in Medicina
Verified
Journal Article
Open access
PDF file
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
Background and Objectives: This study aimed to investigate the anticancer effects and potential synergistic interactions of quercetin (Q) and doxorubicin (Dox) on the MG-63 osteosarcoma (OS) cell line. Specifically, the effects of these agents on cell viability, apoptosis, reactive oxygen species (ROS) generation, antioxidant defense, and the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt1) signaling pathway were evaluated. Material and Methods: MG-63 cells were cultured and treated with varying concentrations of Q and Dox, both individually and in combination (fixed 5:1 molar ratio), for 48 h. Cell viability was assessed using an MTT assay, and IC50 values were calculated. Synergistic effects were analyzed using the Chou–Talalay combination index (CI). Apoptosis was evaluated via Annexin V-FITC/PI staining and caspase-3/7 activity. ROS levels were quantified using DCFH-DA probe, and antioxidant enzymes (SOD, GPx) were measured spectrophotometrically. Gene expression (Runx2, PI3K, Akt1, caspase-3) was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: Q and Dox reduced cell viability in a dose-dependent manner, with IC50 values of 70.3 µM and 1.14 µM, respectively. The combination treatment exhibited synergistic cytotoxicity (CI < 1), especially in the Q50 + Dox5 group (CI = 0.23). Apoptosis was significantly enhanced in the combination group, evidenced by increased Annexin V positivity and caspase-3 activation. ROS levels were markedly elevated, while antioxidant enzyme activities declined. RT-qPCR revealed upregulation of caspase-3 and downregulation of Runx2, PI3K, and Akt1 mRNA levels. Conclusions: The combination of Q and Dox exerts synergistic anticancer effects in MG-63 OS cells by inducing apoptosis, elevating oxidative stress, suppressing antioxidant defense, and inhibiting the PI3K/Akt1 signaling pathway and Runx2 expression. These findings support the potential utility of Q as an adjuvant to enhance Dox efficacy in OS treatment.

Verified
Journal Article
Open access
PDF file
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
The increasing resistance to chemotherapeutic agents in lung cancer significantly contributes to its high mortality. Natural compounds such as acetyl-11-keto-β-boswellic acid (AKBA) have emerged as promising adjuncts to standard therapies. This study investigated the synergistic apoptotic and cytotoxic effects of AKBA in combination with cisplatin (Cis) on A549 non-small-cell lung cancer (NSCLC) cells. Cell viability, apoptosis, and gene expression were evaluated using MTS assay, Annexin V-FITC/PI staining, caspase activity, RT-qPCR, and ELISA, complemented by molecular docking (AKBA–p53) and molecular dynamics (AKBA–p53 and Cis–p53) analyses. Combined AKBA + Cis treatment significantly enhanced apoptosis and reduced cell viability compared to monotherapies (p < 0.001), accompanied by upregulation of p53 and caspase-3 and suppression of NF-κB. In silico results further supported direct and stable binding of p53, particularly with AKBA. These findings indicate that AKBA synergizes with Cis to potentiate apoptotic and anti-inflammatory responses in NSCLC and may provide a novel dose-sparing strategy with improved therapeutic efficacy, warranting further in vivo validation.

15 November 2024 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
EAEsranur Atiç
Esranur Atiç
MSMuhyiddin Sancar
Muhyiddin Sancar
MKMehmet Uğur Karabat
Mehmet Uğur Karabat
ŞKŞehmus Kaplan
Şehmus Kaplan
Fırat AşırFırat Aşır
Fırat Aşır
MAMurat Akkuş
Murat Akkuş
This study investigates histopathological changes in ovarian tissues of rats subjected to ischemia-reperfusion (I/R) injury, a condition where restored blood flow causes cellular stress and potential damage. Rats were divided into three groups: control, ischemia, and ischemia-reperfusion. Histological analysis revealed that ischemic ovaries exhibited increased follicular degeneration, atretic follicles, and inflammatory infiltration. The ischemia-reperfusion group showed even more pronounced damage, including disrupted cellular structures and severe vascular congestion. These findings highlight the exacerbated tissue damage caused by reperfusion, underscoring the complex impact of I/R injury on ovarian tissue integrity. Keywords: ovary, ischemia, reperfusion, histology